Focused radiation after brain tumor surgery
Part of Brain & nervous system, Cancer clinical trials.
This study tests a type of radiation called stereotactic radiosurgery (SRS) given right after surgery to remove a brain tumor. The goal is to see if it helps control the tumor with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a type of cancer that started in the breast, lung, skin (melanoma), or gastrointestinal tract.
- You must have a brain tumor (metastasis) that is 6 cm or smaller and is planned to be removed with surgery.
- You must not have had whole-brain radiation before.
- You must not have had any prior brain surgery (open surgery) or a brain biopsy.
- You must be able to have an MRI of the brain with contrast.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a type of focused radiation (stereotactic radiosurgery, or SRS) for people with small cell lung cancer that has spread to the brain. It looks at whether this approach can treat brain metastases when the cancer has limited to a certain number of spots.
This study tests giving a single, precise dose of radiation to a brain metastasis just before surgery, to see if it helps control the tumor better without extra side effects. It’s for people who are already planning surgery for a medium-to-large brain tumor that started from another cancer.
This trial tests giving powerful, precise radiation (stereotactic radiosurgery) to large brain tumors before surgery, then using more radiation after surgery. It aims to see if this approach can control the tumor better while reducing side effects.
This study is for people with melanoma or lung cancer that has spread to the brain and who have had surgery to remove the brain tumor. It looks at whether it is safe to skip the usual radiation treatment after surgery, while taking a targeted drug therapy that is known to be effective in the brain.
This study compares giving focused, high-precision radiation before or after surgery for brain metastases. It aims to see which timing works best to control tumors and improve outcomes.
This trial compares giving stereotactic radiosurgery (focused radiation) before versus after surgery to remove brain metastases. It aims to see which timing may help control the cancer while possibly reducing side effects on thinking and memory.
Hear when a new Brain Metastasases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.